Altcoin Season Soon: Not a Trap, List of Altcoins That Have Survived the Storm

1 month ago 18
Altcoins

The post Altcoin Season Soon: Not a Trap, List of Altcoins That Have Survived the Storm appeared first on Coinpedia Fintech News

Bitcoin could reach new all-time highs, and altcoins are poised for a significant rebound, according to the analyst of Crypto Banter’s The Sniper Trading Show. While the bulls are holding firm with a solid support line, the analyst said that one  needs to brace for another pullback on the horizon. This upcoming dip may create prime buying opportunities for savvy investors.

He explained that the recent market movements have provided clarity on which tokens are resilient and poised for growth. The bullish sentiment is gradually returning, and it’s important to focus on coins that have shown strength in past rallies.

Key Altcoins to Watch

Injective (INJ): Injective is at a pivotal point, showing a higher low, which suggests potential for upward movement. As an investor, this is an encouraging sign; breakouts from this zone could lead to significant gains.

Fantom (FTM): Phantom remains bullish but is currently experiencing a pullback. The analyst suggests that if it retraces to around $0.55–$0.50, it could present an attractive buying opportunity. Should Phantom successfully retest this zone, it may be poised for a significant rally.

Thorchain (RUNE): Thorchain is also showing promise. If it retraces to the $4.50–$5.00 range, this could be an ideal entry point for investors looking to capitalize on its potential upside.

Stacks (STX): This token presents a solid entry point for investors looking for promising assets in the current market.

Dogecoin (DOGE): Interest in meme coins is also resurging, with talk of a potential “meme coin supercycle.” This could lead to new opportunities in tokens traditionally considered speculative.

Conclusion: 

Last week’s sudden decline was likely driven by panic over news events, but it serves as a reminder to stay calm. We may be headed for another retest soon, but there are still opportunities ahead.

Read Entire Article